Advertisement
Screener

SERA PROGNOSTICS, INC. (SERA) Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss

SERA PROGNOSTICS, INC. Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss

SERA PROGNOSTICS, INC. (SERA) had Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss of $11.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss · last filed 2026-08-12

  • 2026-06-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss $11.00K.
  • 2026-03-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss $7.00K.
  • 2025-12-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss $0.00.
  • 2025-09-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss $8.00K.
Period endDebt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss
2026-06-30$11.00K
10-Q · filed 2026-08-12
2026-03-31$7.00K
10-Q · filed 2026-05-06
2025-12-31$0.00
10-Q · filed 2026-08-12
2025-09-30$8.00K
10-Q · filed 2025-11-13
2025-06-30$0.00
10-Q · filed 2025-08-06
2025-03-31$1.00K
10-Q · filed 2025-05-07
2024-12-31$2.00K
10-K · filed 2026-03-18
2024-09-30$8.00K
10-Q · filed 2024-11-06
2024-06-30$93.00K
10-Q · filed 2024-08-07
2024-03-31$64.00K
10-Q · filed 2024-05-08
2023-12-31$140.00K
10-K · filed 2025-03-19
2023-09-30$219.00K
10-Q · filed 2023-11-08
2023-06-30$114.00K
10-Q · filed 2023-08-09
2023-03-31$146.00K
10-Q · filed 2023-05-10
2022-12-31$473.00K
10-K · filed 2024-03-20
2022-09-30$513.00K
10-Q · filed 2022-11-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45